We announced positive late-breaking data for CTX310 at @escardio Congress, demonstrating deep and durable reductions in circulating ANGPTL3, triglycerides, and LDL sustained through one year of follow-up. The data are also published in @NEJM. bit.ly/4xlm9ME#ESCCongress
Our CEO Samarth Kulkarni @CrisprSam joined the Biotech CEO Panel at the @BiotechTV U.S. Science Summit alongside Nello Mainolfi, Jason Kelly, and Kendalle Burlin O'Connell to discuss where the science and industry are headed. Thanks to @bradloncar and @BiotechTV for hosting us.
A meaningful moment for children and their families. The FDA has approved expanded use of a one-time CRISPR/Cas9 gene-edited treatment, co-developed with Vertex, for children as young as 2 years old with #SickleCellDisease or #BetaThalassemia.
May is #NationalCancerResearchMonth, highlighting the critical role of research in advancing cancer prevention, diagnosis, and treatment. We recognize all of the individuals working tirelessly to improve cancer outcomes. Learn more from @AACR: aacr.org
